Audience-induced inhibition of overt practice during learning.

Three experiments with 204 undergraduates examined the hypothesis that an audience can inhibit overt practice and thereby impair learning of unfamiliar words and enhance learning of familiar words. This hypothesis was derived from an analysis of motoric and symbolic mediation during learning. In comparison with learning while alone, the results show that the audience inhibited overt practice of unfamiliar and familiar words and that reduced practice was detrimental to learning unfamiliar words. Inhibition of overt practice with an audience enhanced learning of familiar words in only 1 of the experiments. Instructions to practice overtly reduced the audience-inhibition effect in learning unfamiliar words. The studies are discussed in the context of drive-theory explanations for social facilitation effects in learning. (20 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Can computers carry content ‘inexplicitly’?

I examine whether it is possible for content relevant to a computer's behavior to be carried without an explicit internal representation. I consider three approaches. First, an example of a chess playing computer carrying emergent content is offered from Dennett. Next I examine Cummins response to this example. Cummins says Dennett's computer executes a rule which is inexplicitly represented. Cummins describes a process wherein a computer interprets explicit rules in its program, implements them to form a chess-playing device, then this device executes the rules in a way that exhibits them inexplicitly. Though this approach is intriguing, I argue that the chess-playing device cannot exist as imagined. The processes of interpretation and implementation produce explicit representations of the content claimed to be inexplicit. Finally, the Chinese Room argument is examined and shown not to save the notion of inexplicit information. This means the strategy of attributing inexplicit content to a computer which is executing a rule, fails.I wish to thank Fred Dretske, JOhn Perry, and an anonymous reviewer for helpful comments and suggestions. Earlier versions of this paper were read at the American Philosophical Association Pacific Division Meeting in San Francisco in March, 1993, and at the 7th International Conference on Computing and Philosophy in Orlando in August, 1992.     

TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy

Orbital fibroblasts (OFs) in thyroid-associated ophthalmopathy (TAO) are differentiated from pre-adipocytes and mature adipocytes; increased lipid and fat expansion are the major characteristics of ophthalmic manifestations. Human placental mesenchymal stem cells (hPMSCs) were reported to immunomodulate pathogenesis and suppress adipogenesis in TAO OFs. Here, we prepared transforming growth factor β (TGFβ, 20 ng/mL)-treated hPMSCs (TGFβ-hPMSCs) in order to enhance anti-adipogenic effects in vitro and in TAO mice. TAO OFs were grown in a differentiation medium and then co-cultured with hPMSCs or TGFβ-hPMSCs. TAO OFs were analyzed via quantitative real-time polymerase chain reaction, Oil red O staining, and western blotting. The results showed that TGFβ-hPMSCs reduced the expression of adipogenic, lipogenic, and fibrotic genes better than hPMSCs in TAO OFs. Moreover, the adipose area decreased more in TAO mice injected with TGFβ-hPMSCs compared to those injected with hPMSCs or a steroid. Further, TGFβ-hPMSCs inhibited inflammation as effectively as a steroid. In conclusion, TGFβ-hPMSCs suppressed adipogenesis and lipogenesis in vitro and in TAO mice, and the effects were mediated by the SMAD 2/3 pathways. Furthermore, TGFβ-hPMSCs exhibited anti-inflammatory and anti-fibrotic functions, which suggests that they could be a new and safe method to promote the anti-adipogenic function of hPMSCs to treat TAO patients.     

A numerical study of a semi‐algebraic multilevel preconditioner for the local discontinuous Galerkin method

In this work, we consider the local discontinuous Galerkin (LDG) method applied to second‐order elliptic problems arising in the modeling of single‐phase flows in porous media. It has been recently proven that the spectral condition number of the stiffness matrix exhibits an asymptotic behavior of ??(h^?2) on structured and unstructured meshes, where h is the mesh size. Thus, efficient preconditioners are mandatory. We present a semi‐algebraic multilevel preconditioner for the LDG method using local Lagrange‐type interpolatory basis functions. We show, numerically, that its performance does not degrade, or at least the number of iterations increases very slowly, as the number of unknowns augments. The preconditioner is tested on problems with high jumps in the coefficients, which is the typical scenario of problems arising in porous media. Copyright © 2007 John Wiley & Sons, Ltd.     

DEPP functionally graded piezoceramics via micro-fabrication by co-extrusion

This paper introduces the Dual Electro/Piezo Property (DEPP) gradient technique via Micro-Fabrication through Co-eXtrusion (MFCX) which pairs a high displacement lead zirconate titanate (PZT) piezoceramic with a high permittivity barium titanate (BT) dielectric. By grading with this material combination spatially across an actuator, the electric field is concentrated in the more active region for improved efficiency, higher displacements, and complex motions. To aid in synthesis and analysis of any gradient profile, compositional maps are provided for key material properties (density, stiffness, permittivity, and piezoelectric coefficients). The DEPP technique was validated, independent of the MFCX process, by powder pressing a conventional bimodal gradient beam which demonstrated through experiments high displacement capabilities at lower driving potentials than comparable functionally graded piezoceramic actuators. For more complex gradients, the MFCX process was adapted to the DEPP gradient technique and illustrated by the fabrication of a linearly graded prototype whose monolithic nature and gradual material variation significantly reduces internal stresses, improves reliability, and extends service lifetime.     

Exciton storage by Mn(2+) in colloidal Mn(2+)-doped CdSe quantum dots

Colloidal Mn (2+)-doped CdSe quantum dots showing long excitonic photoluminescence decay times of up to tau exc = 15 mus at temperatures over 100 K are described. These decay times exceed those of undoped CdSe quantum dots by approximately 10 (3) and are shown to arise from the creation of excitons by back energy transfer from excited Mn (2+) dopant ions. A kinetic model describing thermal equilibrium between Mn (2+ 4)T 1 and CdSe excitonic excited states reproduces the experimental observations and reveals that, for some quantum dots, excitons can emit with near unity probability despite being approximately 100 meV above the Mn (2+ 4)T 1 state. The effect of Mn (2+) doping on CdSe quantum dot luminescence at high temperatures is thus completely opposite from that at low temperatures described previously.     

Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that arises due to a complex and variable interplay between elements including age, genetic, and environmental risk factors that manifest as the loss of dopaminergic neurons. Contemporary treatments for PD do not prevent or reverse the extent of neurodegeneration that is characteristic of this disorder and accordingly, there is a strong need to develop new approaches which address the underlying disease process and provide benefit to patients with this debilitating disorder. Mitochondrial dysfunction, oxidative damage, and inflammation have been implicated as pathophysiological mechanisms underlying the selective loss of dopaminergic neurons seen in PD. However, results of studies aiming to inhibit these pathways have shown variable success, and outcomes from large-scale clinical trials are not available or report varying success for the interventions studied. Overall, the available data suggest that further development and testing of novel therapies are required to identify new potential therapies for combating PD. Herein, this review reports on the most recent development of antioxidant and anti-inflammatory approaches that have shown positive benefit in cell and animal models of disease with a focus on supplementation with natural product therapies and selected synthetic drugs.